SEC 13F Intelligence

Samson Rock Capital LLP / CNST

Samson Rock Capital LLP’s Constellation Pharmceticls I Position

Does Samson Rock Capital LLP own Constellation Pharmceticls I (CNST)? Not currently — the last reported position was 467.1K shares worth $16M in Q2 2021; the fund’s latest 13F (Q2 2026) no longer reports it.

Position Value
$16M
Q2 2021
Shares
467.1K
% of Portfolio
+3.11%
Quarters Held
1
position exited

Position History CNST

Reported value by quarter
Q2 ’21: $16MQ2 ’21filingsflow.com
QuarterSharesValue% of Portfolio
Q2 2021467.1K$16M+3.11%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Samson Rock Capital LLP’s full portfolio or all institutional holders of CNST.